Gene expression profiling in sinonasal adenocarcinoma

BMC Medical Genomics

Volumn 2, Issue , 2009, Pages

  Tripodi, Dominique ^a,b   Quéméner, Sylvia ^b   Renaudin, Karine ^b,c   Ferron, Christophe ^c   Malard, Olivier ^c   Guisle Marsollier, Isabelle ^b   Sébille Rivain, Véronique ^b   Verger, Christian ^d   Géraut, Christian ^c   Gratas Rabbia Ré, Catherine ^a,c  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d CH Htel Dieu   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A; BIOLOGICAL MARKER; CLUSTERIN; GALECTIN 4; ACSL5 PROTEIN, HUMAN; CLU PROTEIN, HUMAN; LGALS4 PROTEIN, HUMAN; LONG CHAIN FATTY ACID COENZYME A LIGASE; TUMOR PROTEIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINONASAL ADENOCARCINOMA; UNINDEXED SEQUENCE; UPREGULATION; DNA MICROARRAY; ETHMOID SINUS; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MIDDLE AGED; PARANASAL SINUS TUMOR; PATHOLOGY;

ADENOCARCINOMA; AGED; CLUSTERIN; COENZYME A LIGASES; ETHMOID SINUS; FEMALE; GALECTIN 4; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARANASAL SINUS NEOPLASMS;

EID: 72049103647     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-2-65     Document Type: Article

References (61)

1. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. P Dulguerov MS Jacobsen AS Allal W Lehmann T Calcaterra, Cancer 2001 92 12 3012 3029 10.1002/1097-0142(20011215)92: 12<3012::AID-CNCR101313.0.CO;2-E 11753979
2. Sinonasal cancer and occupational exposures: a pooled analysis of 12 case-control studies. D Luce A Leclerc D Begin PA Demers M Gerin E Orlowski M Kogevinas S Belli I Bugel U Bolm-Audorff LA Brinton P Comba L Hardell RB Hayes C Magnani E Merler S Preston-Martin TL Vaughan W Zheng P Boffetta, Cancer Causes Control 2002 13 2 147 157 10.1023/A:1014350004255 11936821
3. Occupational risks for adenocarcinoma of the nasal cavity and paranasal sinuses in the German wood industry. B Pesch CB Pierl M Gebel I Gross D Becker G Johnen HP Rihs K Donhuijsen V Lepentsiotis M Meier J Schulze T Bruening, Occup Environ Med 2007 65 3 191 196 10.1136/oem.2007.033886 17881467
4. Wood dust and formaldehyde. IARC, Monogr Eval Carcinog Risks Hum Lyon: IARC, IARC, 1995 62
5. Pooled reanalysis of cancer mortality among five cohorts of workers in wood-related industries. PA Demers P Boffetta M Kogevinas A Blair BA Miller CF Robinson RJ Roscoe PD Winter D Colin E Matos, et al. Scand J Work Environ Health 1995 21 3 179 190 7481605
6. Cancer risk from occupational exposure to wood dust. A pool analysis of epidemiological studies. IARC, Tech Rep, IARC, 1998 30
7. IARC Monogr Eval Carcinog Risks Hum. Leather industries, boot and shoe manufacture and repair. IARC, Overall evaluations of carcinogenicity: an updating of IARC monographs Lyon: IARC 1987 1-42 232 237
8. Sino-nasal cancer and exposure to leather dust. V Bonneterre E Deschamps R Persoons C Bernardet S Liaudy A Maitre R de Gaudemaris, Occup Med (Lond) 2007 57 6 438 443 10.1093/occmed/kqm050 17591601
9. Work-related cancer in the Nordic countries. A Andersen L Barlow A Engeland K Kjaerheim E Lynge E Pukkala, Scand J Work Environ Health 1999 25 Suppl 2 1 116 10507118
10. Nasal and sinonasal cancer. Connection with occupational exposures in Denmark, Finland and Sweden. S Hernberg P Westerholm K Schultz-Larsen R Degerth E Kuosma A Englund U Engzell HS Hansen P Mutanen, Scan J Work Environ Health 1983 9 315 326
11. Mortality from solid cancers among workers in formaldehyde industries. M Hauptmann JH Lubin PA Stewart RB Hayes A Blair, Am J Epidemiol 2004 159 12 1117 1130 10.1093/aje/kwh174 15191929
12. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. SS Hecht, Nat Rev Cancer 2003 3 10 733 744 10.1038/nrc1190 14570033
13. Genetic and clinical aspects of wood dust related intestinal-type sinonasal adenocarcinoma: a review. JL Llorente J Perez-Escuredo C Alvarez-Marcos C Suarez M Hermsen, Eur Arch Otorhinolaryngol 2009 266 1 1 7 10.1007/s00405-008-0749-y 18560862
14. Clinical and pathological considerations in the evaluation of major head and neck specimens resected for cancer. Part II. L Barnes JT Johnson, Pathol Annu 1986 21 Pt 2 83 110 3529009
15. Adenocarcinomas of the inner nose after exposure to wood dust. Morphological findings and relationships between histopathology and clinical behavior in 79 cases. O Kleinsasser HG Schroeder, Arch Otorhinolaryngol 1988 245 1 1 15 10.1007/BF00463541 2839136
16. Subcranial fronto-orbito-nasal approach for ethmoidal cancers surgical techniques and results. FX Roux R Moussa B Devaus F Nataf P Page O Laccourreye G Schwaab D Brasnu J Lacau Saint-Guily, Surg Neurol 1999 52 5 501 508 10.1016/S0090-3019(99)00127-5 10595771
17. Prognostic factors in sinonasal tumors involving the anterior skull base. C Suarez JL Llorente R Fernandez De Leon E Maseda A Lopez, Head Neck 2004 26 2 136 144 10.1002/hed.10358 14762882
18. K-ras mutations in sinonasal cancers in relation to wood dust exposure. J Bornholdt J Hansen T Steiniche M Dictor A Antonsen H Wolff V Schlunssen R Holmila D Luce U Vogel K Husgafvel-Pursiainen H Wallin, BMC Cancer 2008 8 53 10.1186/1471-2407-8-53 18289366
19. COX-2 and p53 in human sinonasal cancer: COX-2 expression is associated with adenocarcinoma histology and wood-dust exposure. R Holmila D Cyr D Luce P Heikkila M Dictor T Steiniche T Stjernvall J Bornholdt H Wallin H Wolff K Husgafvel-Pursiainen, Int J Cancer 2008 122 9 2154 2159 10.1002/ijc.23360 18186150
20. Comparative genomic hybridization in primary sinonasal adenocarcinomas. M Ariza JL Llorente C Alvarez-Marcas L Baragano A Salas N Rodriguez Prado M Hermsen C Suarez A Sampedro, Cancer 2004 100 2 335 341 10.1002/cncr.11931 14716769
21. Chromosomal imbalances in wood dust-related adenocarcinomas of the inner nose and their associations with pathological parameters. D Korinth M Pacyna-Gengelbach N Deutschmann S Hattenberger U Bockmuhl M Dietel HG Schroeder K Donhuijsen I Petersen, J Pathol 2005 207 2 207 215 10.1002/path.1819 16041693
22. Genome-wide analysis of genetic changes in intestinal-type sinonasal adenocarcinoma. MA Hermsen JL Llorente J Perez-Escuredo F Lopez B Ylstra C Alvarez-Marcos C Suarez, Head Neck 2009 31 3 290 297 10.1002/hed.20973 19073009
23. Genetic damage in wood dust-exposed workers. PV Rekhadevi M Mahboob MF Rahman P Grover, Mutagenesis 2009 24 1 59 65 10.1093/mutage/gen053 18815121
24. Adenocarcinoma. A Franchi M Santucci B Wenig, World Health Organization classification of tumors Pathology and genetics of head and neck tumours Lyon: IARC, Barnes L, Eveson J, Reichart P, Sidransky D, 2005 20 23
25. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. L Barnes, Am J Surg Pathol 1986 10 3 192 202 10.1097/00000478-198603000-00006 3953940
26. RNA integrity and the effect on the real-time qRT-PCR performance. S Fleige MW Pfaffl, Mol Aspects Med 2006 27 2-3 126 139 10.1016/j.mam.2005.12.003 16469371
27. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. H Was T Cichon R Smolarczyk D Rudnicka M Stopa C Chevalier JJ Leger B Lackowska A Grochot K Bojkowska A Ratajska C Kieda S Szala J Dulak A Jozkowicz, Am J Pathol 2006 169 6 2181 2198 10.2353/ajpath.2006.051365 17148680
28. Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells. K Mori M Berreur F Blanchard C Chevalier I Guisle-Marsollier M Masson F Redini D Heymann, Oncol Rep 2007 18 6 1365 1371 17982618
29. Molecular profiles of Quadriceps muscle in myostatin-null mice reveal PI3K and apoptotic pathways as myostatin targets. I Chelh B Meunier B Picard MJ Reecy C Chevalier JF Hocquette I Cassar-Malek, BMC Genomics 2009 10 196 10.1186/1471-2164-10-196 19397818
30. Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man. G Lamirault N Gaborit N Le Meur C Chevalier G Lande S Demolombe D Escande S Nattel JJ Leger M Steenman, J Mol Cell Cardiol 2006 40 1 173 184 10.1016/j.yjmcc.2005.09.004 16242148
31. A dynamic, web-accessible resource to process raw microarray scan data into consolidated gene expression values: importance of replication. N Le Meur G Lamirault A Bihouee M Steenman H Bedrine-Ferran R Teusan G Ramstein JJ Leger, Nucleic Acids Res 2004 32 18 5349 5358 10.1093/nar/gkh870 15475389
32. Significance analysis of microarrays applied to the ionizing radiation response. VG Tusher R Tibshirani G Chu, Proc Natl Acad Sci USA 2001 98 9 5116 5121 10.1073/pnas.091062498 11309499
33. Cluster analysis and display of genome-wide expression patterns. MB Eisen PT Spellman PO Brown D Botstein, Proc Natl Acad Sci USA 1998 95 25 14863 14868 10.1073/pnas.95.25.14863 9843981
34. GoMiner: a resource for biological interpretation of genomic and proteomic data. BR Zeeberg W Feng G Wang MD Wang AT Fojo M Sunshine S Narasimhan DW Kane WC Reinhold S Lababidi KJ Bussey J Riss JC Barrett JN Weinstein, Genome Biol 2003 4 4 28 10.1186/gb-2003-4-4-r28 12702209
35. A new mathematical model for relative quantification in real-time RT-PCR. MW Pfaffl, Nucleic Acids Res 2001 29 9 45 10.1093/nar/29.9.e45 11328886
36. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. MW Pfaffl GW Horgan L Dempfle, Nucleic Acids Res 2002 30 9 36 10.1093/nar/30.9.e36 11972351
37. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. B Shannan M Seifert K Leskov J Willis D Boothman W Tilgen J Reichrath, Cell Death Differ 2006 13 1 12 19 10.1038/sj.cdd.4401779 16179938
38. Galectin-4 in normal tissues and cancer. ME Huflejt H Leffler, Glycoconj J 2004 20 4 247 255 10.1023/B:GLYC.0000025819.54723.a0 15115909
39. Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle. D Paclik S Danese U Berndt B Wiedenmann A Dignass A Sturm, PLoS ONE 2008 3 7 2629 10.1371/journal.pone.0002629 18612433
40. Galectin-2 and -4, but not galectin-1, promote intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism. D Paclik K Lohse B Wiedenmann AU Dignass A Sturm, Inflamm Bowel Dis 2008 14 10 1366 1372 10.1002/ibd.20499 18484670
41. Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis. EM Duerr Y Mizukami A Ng RJ Xavier H Kikuchi V Deshpande AL Warshaw J Glickman MH Kulke DC Chung, Endocr Relat Cancer 2008 15 1 243 256 10.1677/ERC-07-0194 18310291
42. Expression of galectins in cancer: a critical review. F van den Brule S Califice V Castronovo, Glycoconj J 2004 19 7-9 537 542 10.1023/B:GLYC. 0000014083.48508.6a 14758077
43. A distinct molecular profile associated with mucinous epithelial ovarian cancer. VA Heinzelmann-Schwarz M Gardiner-Garden SM Henshall JP Scurry RA Scolyer AN Smith A Bali P Vanden Bergh S Baron-Hay C Scott D Fink NF Hacker RL Sutherland PM O'Brien, Br J Cancer 2006 94 6 904 913 10.1038/sj.bjc.6603003 16508639
44. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. R Romieu-Mourez DW Kim SM Shin EG Demicco E Landesman-Bollag DC Seldin RD Cardiff GE Sonenshein, Mol Cell Biol 2003 23 16 5738 5754 10.1128/MCB.23.16.5738-5754. 2003 12897145
45. NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy. HM Shen V Tergaonkar, Apoptosis 2009 14 4 348 363 10.1007/s10495-009-0315-0 19212815
46. Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control. B Shannan M Seifert DA Boothman W Tilgen J Reichrath, J Mol Histol 2006 37 5-7 183 188 10.1007/s10735-006-9052-7 17048076
47. Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. I Martinez J Wang KF Hobson RL Ferris SA Khan, Eur J Cancer 2007 43 2 415 432 10.1016/j.ejca.2006.09.001 17079134
48. Advances and challenges in basic and translational research on clusterin. IP Trougakos JY Djeu ES Gonos DA Boothman, Cancer Res 2009 69 2 403 406 10.1158/0008-5472.CAN-08-2912 19147550
49. High clusterin expression correlates with a poor outcome in stage II colorectal cancers. D Kevans J Foley M Tenniswood K Sheahan J Hyland D O'Donoghue H Mulcahy J O'Sullivan, Cancer Epidemiol Biomarkers Prev 2009 18 2 393 399 10.1158/1055-9965.EPI-08-0302 19155441
50. Expression of potential molecular markers in renal cell carcinoma: impact on clinicopathological outcomes in patients undergoing radical nephrectomy. I Sakai H Miyake A Takenaka M Fujisawa, BJU Int 2009 104 7 942 946 10.1111/j.1464-410X.2009.08591.x
51. Human clusterin (CLI) maps to 8p21 in proximity to the lipoprotein lipase (LPL) gene. TM Fink M Zimmer J Tschopp J Etienne DE Jenne P Lichter, Genomics 1993 16 2 526 528 10.1006/geno.1993.1222 8314591
52. Long-chain acyl-CoA-dependent regulation of gene expression in bacteria, yeast and mammals. PN Black NJ Faergeman CC DiRusso, J Nutr 2000 130 2S Suppl 305S 309S 10721893
53. Expression of acyl-CoA synthetase 5 reflects the state of villus architecture in human small intestine. N Gassler J Kopitz A Tehrani B Ottenwalder M Schnolzer J Kartenbeck S Lyer F Autschbach A Poustka HF Otto J Mollenhauer, J Pathol 2004 202 2 188 196 10.1002/path.1504 14743501
54. Impaired expression of acyl-CoA-synthetase 5 in epithelial tumors of the small intestine. N Gassler A Schneider J Kopitz M Schnolzer N Obermuller J Kartenbeck HF Otto F Autschbach, Hum Pathol 2003 34 10 1048 1052 10.1053/S0046-8177(03)00431-3 14608540
55. Fatty acid induced glioma cell growth is mediated by the acyl-CoA synthetase 5 gene located on chromosome 10q25.1-q25.2, a region frequently deleted in malignant gliomas. Y Yamashita T Kumabe YY Cho M Watanabe J Kawagishi T Yoshimoto T Fujino MJ Kang TT Yamamoto, Oncogene 2000 19 51 5919 5925 10.1038/sj.onc.1203981 11127823
56. Expression of acyl-CoA synthetase 5 in human endometrium and in endometrioid adenocarcinomas. N Gassler SH Yang M Keith BM Helmke P Schirmacher N Obermuller, Histopathology 2005 47 5 501 507 10.1111/j.1365-2559.2005.02255.x 16241998 (Pubitemid 41626728)
57. Impaired expression of acyl-CoA synthetase 5 in sporadic colorectal adenocarcinomas. N Gassler I Herr A Schneider R Penzel L Langbein P Schirmacher J Kopitz, J Pathol 2005 207 3 295 300 10.1002/path.1831 16110457 (Pubitemid 41556453)
58. Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers. A Ooe K Kato S Noguchi, Breast Cancer Res Treat 2007 101 3 305 315 10.1007/s10549-006- 9293-x 16821082
59. Sorcin, an important gene associated with multidrug-resistance in human leukemia cells. Y Zhou Y Xu Y Tan J Qi Y Xiao C Yang Z Zhu D Xiong, Leuk Res 2006 30 4 469 476 10.1016/j.leukres.2005.08.024 16213583
60. Identification of differentially expressed genes in tobacco chewing-mediated oral cancer by differential display-polymerase chain reaction. JK Nagpal BR Das, Eur J Clin Invest 2007 37 8 658 664 10.1111/j.1365-2362.2007. 01841.x 17635577
61. TNM staging of cancers of the head and neck: striving for uniformity among diversity. SG Patel JP Shah, CA Cancer J Clin 2005 55 4 242 258 10.3322/canjclin.55.4.242 16020425